Hap Trading, LLC Relmada Therapeutics, Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 139,400 shares of RLMD stock, worth $361,046. This represents 0.11% of its overall portfolio holdings.
Number of Shares
139,400Holding current value
$361,046% of portfolio
0.11%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RLMD
# of Institutions
56Shares Held
5.43MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$1.92 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA619KShares$1.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$1.48 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD403KShares$1.05 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$942,9590.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $74.1M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...